LIGAND PHARMACEUTICALS INC financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 915% % -42%
Quick Ratio 29% % -72%
Debt-to-equity 26% % 100%
Return On Equity 6% % -1.4%
Return On Assets 5% % -11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19,681,720 shares 4.2%
Common Stock, Shares, Outstanding 19,656,000 shares 4.8%
Entity Public Float $1,100,000,000 USD 22%
Common Stock, Value, Issued $20,000 USD 5.3%
Weighted Average Number of Shares Outstanding, Basic 19,578,000 shares 6.3%
Weighted Average Number of Shares Outstanding, Diluted 20,629,000 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $251,233,000 USD 65%
Research and Development Expense $82,096,000 USD 265%
General and Administrative Expense $93,027,000 USD 35%
Operating Income (Loss) $17,522,000 USD 1648%
Nonoperating Income (Expense) $45,458,000 USD -40%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $62,980,000 USD 7.1%
Income Tax Expense (Benefit) $14,399,000 USD 6.1%
Net Income (Loss) Attributable to Parent $48,581,000 USD 7.4%
Earnings Per Share, Basic 2 USD/shares -15%
Earnings Per Share, Diluted 2 USD/shares -21%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $139,376,000 USD 119%
Accounts Receivable, after Allowance for Credit Loss, Current $57,560,000 USD 68%
Inventory, Net $11,900,000 USD -29%
Other Assets, Current $6,986,000 USD -65%
Assets, Current $753,920,000 USD 144%
Deferred Income Tax Assets, Net $9,526,000 USD 12113%
Property, Plant and Equipment, Net $3,466,000 USD -77%
Operating Lease, Right-of-Use Asset $7,609,000 USD 6.3%
Intangible Assets, Net (Excluding Goodwill) $233,535,000 USD -15%
Goodwill $101,541,000 USD -3.5%
Other Assets, Noncurrent $2,771,000 USD -67%
Assets $1,476,772,000 USD 55%
Accounts Payable, Current $3,679,000 USD -22%
Employee-related Liabilities, Current $3,696,000 USD -3.5%
Accrued Liabilities, Current $24,084,000 USD 54%
Contract with Customer, Liability, Current $621,000 USD -46%
Liabilities, Current $30,539,000 USD 23%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Deferred Income Tax Liabilities, Net $22,673,000 USD -51%
Operating Lease, Liability, Noncurrent $4,415,000 USD -30%
Other Liabilities, Noncurrent $19,912,000 USD -33%
Liabilities $526,601,000 USD 363%
Accumulated Other Comprehensive Income (Loss), Net of Tax $9,322,000 USD 434%
Retained Earnings (Accumulated Deficit) $578,215,000 USD 9.1%
Stockholders' Equity Attributable to Parent $950,171,000 USD 13%
Liabilities and Equity $1,476,772,000 USD 55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,445,000 USD -236%
Net Cash Provided by (Used in) Financing Activities $4,747,000 USD -139%
Net Cash Provided by (Used in) Investing Activities $4,894,000 USD
Common Stock, Shares Authorized 60,000,000 shares 0%
Common Stock, Shares, Issued 19,656,000 shares 4.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $27,139,000 USD -38%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $139,376,000 USD 119%
Interest Paid, Excluding Capitalized Interest, Operating Activities $97,000 USD 64%
Deferred Tax Assets, Valuation Allowance $55,649,000 USD -3.6%
Deferred Tax Assets, Gross $96,338,000 USD -7.2%
Operating Lease, Liability $7,081,000 USD 15%
Payments to Acquire Property, Plant, and Equipment $214,000 USD 104%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $56,157,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid $9,482,000 USD 7.6%
Property, Plant and Equipment, Gross $23,401,000 USD 5.1%
Operating Lease, Liability, Current $1,089,000 USD 2.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,637,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,537,000 USD 47%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,983,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,634,000 USD 33%
Deferred Tax Assets, Operating Loss Carryforwards $40,385,000 USD -12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $19,865,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,560,000 USD 24%
Additional Paid in Capital $362,614,000 USD 17%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $8,770,000 USD 0.06%
Deferred Tax Assets, Net of Valuation Allowance $40,689,000 USD -12%
Interest Expense $557,000 USD -55%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%